Eubiologics Co Ltd (206650)

KOSDAQ
Currency in KRW
13,410
+180(+1.36%)
Closed·
206650 Scorecard
Full Analysis
Suffers from weak gross profit margins
Earnings results expected today
Fair Value
Day's Range
13,26013,770
52 wk Range
9,35018,800
Key Statistics
Edit
Bid/Ask
13,400.00 / 13,410.00
Prev. Close
13,230
Open
13,330
Day's Range
13,260-13,770
52 wk Range
9,350-18,800
Volume
320.19K
Average Volume (3m)
179.59K
1-Year Change
3.97%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
206650 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a poor free cash flow yield
No news in this category
Looks like there are no results in this news category

Eubiologics Company Profile

EuBiologics Co., Ltd., a biopharmaceutical company, provides vaccines for epidemics in South Korea. It offers Euvichol Plus, an oral cholera prevention vaccine; and rCRM197, a diphtheria toxoid vaccine. The company also provides EcML, a vaccine for cell membrane, as well as offers COVID-19 diagnostic kits. In addition, it offers CMO services comprising of drug product production, cell bank production, and drug substance production. Further, the company provides CRMO services, including cell line development, GMP production, validation, and the regulatory support; and operates facilities that manufacture protein-based therapeutics and antibodies. Additionally, it offers contract testing services that include lot release, stability, raw material, and method validation testing services. EuBiologics Co., Ltd. was founded in 2010 and is headquartered in Seoul, South Korea.

Compare 206650 to Peers and Sector

Metrics to compare
206650
Peers
Sector
Relationship
P/E Ratio
0.0x−4.1x−0.5x
PEG Ratio
0.00−0.080.00
Price/Book
0.0x1.9x2.6x
Price / LTM Sales
0.0x13.1x2.9x
Upside (Analyst Target)
0.0%20.6%53.0%
Fair Value Upside
Unlock3.7%8.9%Unlock

Earnings

Latest Release
Feb 26, 2025
EPS / Forecast
-348.83 / --
Revenue / Forecast
26.89B / 46.50B
EPS Revisions
Last 90 days

FAQ

What Is the Eubiologics (206650) Stock Price Today?

The Eubiologics stock price today is 13,410.00.

What Stock Exchange Does Eubiologics Trade On?

Eubiologics is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Eubiologics?

The stock symbol for Eubiologics is "206650."

What Is the Eubiologics Market Cap?

As of today, Eubiologics market cap is 484.54B.

What Is Eubiologics's Earnings Per Share (TTM)?

The Eubiologics EPS (TTM) is -380.79.

When Is the Next Eubiologics Earnings Date?

Eubiologics will release its next earnings report on 12 May 2025.

From a Technical Analysis Perspective, Is 206650 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.